Cargando…
PSAT082 A Survey of Patients Living with CAH Assessing Their Perceptions on Glucocorticoid Regimen and Glucocorticoid-Associated Side Effects
BACKGROUND: Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) is an autosomal recessive disorder characterized by insufficient cortisol production resulting in excess adrenal androgen production. The standard of care to replace the insufficient cortisol production is the...
Autores principales: | Barnes, Chris, Dias, Rosh, Feather, Melodie, Sherpa-Pine, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624596/ http://dx.doi.org/10.1210/jendso/bvac150.233 |
Ejemplares similares
-
PSAT095 Examination of Treatment Patterns in Patients with Classic Congenital Adrenal Hyperplasia (CAH) Compared to Treatment Guidelines
por: Manahan, Rachel, et al.
Publicado: (2022) -
RF09 | PSAT70 Comparison of Prednisolone Versus Modified-release Hydrocortisone (Efmody) in the Treatment of Congenital Adrenal Hyperplasia (CAH)
por: Merke, Deborah P, et al.
Publicado: (2022) -
RF33 | PSAT92 Glucocorticoid Excess Alters Metabolic Rate in Male and Female C57BL/6J Mice
por: Tsintzas, Kostas, et al.
Publicado: (2022) -
RF21 | PSAT78 The beta3-Adrenergic Receptor as a Target for the Prevention of Glucocorticoid-induced Adipose Tissue Dysfunction in Rodents
por: Gado, Manuel, et al.
Publicado: (2022) -
PSAT052 Iatrogenic Cushing's Syndrome With a Remote History of Synthetic Glucocorticoid Use in the Setting of a CYP3A4 Inhibitor – Location Matters
por: Hand, Jane, et al.
Publicado: (2022)